Lipiflow Treatment Alone vs. Lipiflow + Dextenza Treatment for Dry Eye Disease
Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the benefit of treatment with a physician administered intracanalicular
dexamethasone insert in evaporative dry eye disease (DED) patients with meibomian gland
disfunction (MGD) and underlying inflammation undergoing LipiFlow Thermal Pulsation.